Carfilzomib falls under the class of medications known as proteasome inhibitors. It works in order to inhibit or resist the growth of cancer cells in a patient's body.

Carfilzomib is a prescription drug introduced for the treatment of adult patients with relapsed/refractory MM who have received one to three previous treatments for multiple myeloma. The cost of carfilzomib may vary from around Rs. 9990 to Rs. 47325 for a supply of a vial of 1 injection.